Camp4 Therapeutics Corp — All Filings
144 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001736730-25-000059 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | FORM 4 | 0001736730-25-000058 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | FORM 4 | 0001736730-25-000057 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | FORM 4 | 0001736730-25-000056 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | FORM 4 | 0001736730-25-000055 | Jun 27, 2025 | Jun 25, 2025 |
| 4 | FORM 4 | 0001736730-25-000054 | Jun 27, 2025 | Jun 25, 2025 |
| 8-K | 8-K | 0001736730-25-000043 | Jun 13, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0001736730-25-000041 | May 16, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-071166 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001736730-25-000039 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001736730-25-000037 | May 13, 2025 | — |
| ARS | ARS | 0001736730-25-000029 | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001736730-25-000028 | Apr 30, 2025 | — |
| DEF 14A | DEF 14A | 0001736730-25-000027 | Apr 30, 2025 | Jun 11, 2025 |
| 3/A | FORM 3/A | 0001628280-25-017487 | Apr 11, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-016486 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-016484 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-016482 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-016481 | Apr 3, 2025 | Apr 1, 2025 |
| S-8 | S-8 | 0001736730-25-000023 | Mar 27, 2025 | — |
| 10-K | 10-K | 0001736730-25-000022 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001736730-25-000021 | Mar 27, 2025 | — |
| 4 | FORM 4 | 0001736730-25-000012 | Mar 19, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001736730-25-000011 | Mar 19, 2025 | Mar 17, 2025 |
| 3 | FORM 3 | 0001736730-25-000010 | Mar 19, 2025 | Mar 17, 2025 |
| 3 | FORM 3 | 0001736730-25-000009 | Mar 19, 2025 | Mar 17, 2025 |
| 8-K | 8-K | 0001736730-25-000004 | Mar 18, 2025 | Mar 12, 2025 |
| 8-K | FORM 8-K | 0001104659-25-001679 | Jan 7, 2025 | — |
| 10-Q | 10-Q | 0001410578-24-002045 | Nov 21, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001104659-24-121533 | Nov 21, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-110632 | Oct 22, 2024 | — |
| SC 13D | SC 13D | 0001193125-24-241180 | Oct 22, 2024 | — |
| 4/A | 4/A | 0000950170-24-116360 | Oct 22, 2024 | Oct 15, 2024 |
| 3/A | 3/A | 0000950170-24-116330 | Oct 22, 2024 | Oct 15, 2024 |
| SC 13G | SC 13G | 0001104659-24-110572 | Oct 22, 2024 | — |
| SC 13D | SC 13D | 0001104659-24-110570 | Oct 22, 2024 | — |
| SC 13D | SC 13D | 0001104659-24-110566 | Oct 22, 2024 | — |
| 4 | — | 0001415889-24-025393 | Oct 17, 2024 | Oct 15, 2024 |
| 4 | — | 0001415889-24-025380 | Oct 17, 2024 | Oct 15, 2024 |
| 4 | — | 0001415889-24-025354 | Oct 17, 2024 | Oct 15, 2024 |
| SEC STAFF LETTER | — | 9999999997-24-004124 | Oct 16, 2024 | — |
| S-8 | FORM S-8 | 0001104659-24-109144 | Oct 16, 2024 | — |
| 4 | 4 | 0000950170-24-114788 | Oct 15, 2024 | — |
| 4 | — | 0001415889-24-025140 | Oct 15, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-108703 | Oct 15, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-108702 | Oct 15, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-108701 | Oct 15, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-108700 | Oct 15, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-108699 | Oct 15, 2024 | — |
| 3 | 3 | 0000950170-24-114773 | Oct 15, 2024 | — |